CORDIS
EU research results

CORDIS

English EN
PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture

Objective

As a consequence of the ageing of the society, osteoporosis (literally “porous bone”) and its complications is becoming more and more prevalent, making the bone disease a health priority in many parts of the world. Currently osteoporosis is commonly known as a “silent killer” disease. Usually osteoporosis manifests itself in a drastic manner, i.e. through fracture of the osteoporotic bone in the affected individual. Until now little or no measures for prevention or early detection of this disease are taken, because no simple, yet sufficiently precise or sensitive tools for early detection of individuals at risk of osteoporosis are available. The overall objective of the currently proposed PoCOsteo project therefore is the development, clinical validation and preparation for commercialisation of a Point-of-Care tool for bone disease (a.o. osteoporisis) prevention, detection and treatment. To realize this objective a balanced consortium of 5 research partners and 3 SME’s has been brought together, and a well considered workplan devised. Two TRL3 technologies for individual proteomic and genomic electrochemical sensors, available from 2 consortium partners will form the base of the developments. The sensors will be further optimised, combined in a single microfluidic cartridge and integrated in a complete and independent point-of-care bone health assessment tool. The tool will consequently be clinically validated in 2 hospitals (Graz and Tehran), and a business plan for a commercial start-up company wil be prepared for the intended valorisation of the technical and medical activities. The aim is to reach a TRL6 / TRL7 for the complete tool and for the combined microfluidci cartridges. The project will be supported and advised by the IOF, the International Osteoporosis Foundation, which is the main global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.

Coordinator

UNIVERSITEIT GENT

Address

Sint Pietersnieuwstraat 25
9000 Gent

Belgium

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 995 018,75

Participants (7)

Sort alphabetically

Sort by EU Contribution

Expand all

UNIVERSITAT ROVIRA I VIRGILI

Spain

EU Contribution

€ 601 291,25

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 397 847,50

microLIQUID sl

Spain

EU Contribution

€ 323 750

LABMAN AUTOMATION LIMITED

United Kingdom

EU Contribution

€ 795 972,50

MEDIZINISCHE UNIVERSITAT GRAZ

Austria

EU Contribution

€ 355 937,50

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

Iran

EU Contribution

€ 361 875

FUNDICO BVBA

Belgium

EU Contribution

€ 172 500

Project information

Grant agreement ID: 767325

Status

Ongoing project

  • Start date

    1 October 2017

  • End date

    30 September 2021

Funded under:

H2020-EU.2.1.1.1.

H2020-EU.2.1.2.

  • Overall budget:

    € 4 004 192,50

  • EU contribution

    € 4 004 192,50

Coordinated by:

UNIVERSITEIT GENT

Belgium